Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) – Not A Clear Buying Opportunity?
Amylyx Pharmaceuticals Inc (AMLX) concluded trading on Thursady at a closing price of $18.54, with 5.68 million shares of worth about $105.31 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.13% during that period and on Thursady the price saw a gain of […]
